Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beamtree HoldingsASX:BMT 29 EV-to-EBIT is -5.44 as of Aug. 10, 2026. GuruFocus rates ASX:BMT with a GF Score™ of 29/100 and a GF Value™ of A$0.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 472 Healthcare Providers & Services companies, Beamtree Holdings ranks worse than 211864.19% on this metric.
The historical rank and industry rank for Beamtree Holdings's EV-to-EBIT or its related term are showing as below:
ASX:BMT'
s EV-to-EBIT Range Over the Past 10 Years
Min: -111.28 Med: -8.81 Max: 313.04
Current: -5.44
During the past 6 years, the highest EV-to-EBIT of Beamtree Holdings was 313.04. The lowest was -111.28. And the median was -8.81.
ASX:BMT's EV-to-EBIT is ranked worse than 100% of 472
companies
in the Healthcare Providers & Services industry
Industry Median: 15.835
vs ASX:BMT: -5.44
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Beamtree Holdings's Enterprise Value for the quarter that ended in Dec. 2025 was A$65.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beamtree Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-6.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beamtree Holdings EV-to-EBIT Related Terms
Beamtree Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Beamtree Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Beamtree Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beamtree Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beamtree Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Beamtree Holdings's EV-to-EBIT falls into.
Beamtree Holdings's current Enterprise Value is A$35.10 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beamtree Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-6.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beamtree Holdings (ASX:BMT) has a EV-to-EBIT of -5.44 as of Aug. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Beamtree Holdings and its competitors. According to the industry distribution chart, Beamtree Holdings ranks #999999 out of 472 companies in the Healthcare Providers & Services industry.
Is Beamtree Holdings' EV-to-EBIT too high?
Beamtree Holdings' current EV-to-EBIT is -5.44. Based on the distribution chart, Beamtree Holdings ranks #999999 out of 472 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Beamtree Holdings has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beamtree Holdings' EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Beamtree Holdings ranks #999999 out of 472 companies for EV-to-EBIT. This places Beamtree Holdings in the lower half of its industry. The industry median EV-to-EBIT is 15.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.84, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Beamtree Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beamtree Holdings's current EV-to-EBIT is -5.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beamtree Holdings stock overvalued right now?
Based on GuruFocus' analysis, Beamtree Holdings (ASX:BMT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.54, compared to a current price of A$0.12 — trading 77.8% below its estimated fair value. The current EV-to-EBIT is -5.44. Beamtree Holdings' overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Beamtree Holdings (ASX:BMT), the current EV-to-EBIT is -5.44 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beamtree Holdings (ASX:BMT) Overvalued in 2026?
Based on GuruFocus' analysis, Beamtree Holdings stock appears to be undervalued.
The current stock price of A$0.12 is trading 77.8% below its estimated GF Value™ of A$0.54.
GuruFocus considers Beamtree Holdings to be Possible Value Trap.
Key valuation signals for ASX:BMT:
EV-to-EBIT: -5.44
GF Value™: A$0.54 vs. price of A$0.12 (77.8% below fair value)
No single metric tells the full story. See the ASX:BMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world.
29GF Score
Get the complete analysis for ASX:BMT
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BMT has been successfully added to your 
